Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Newcastle disease" patented technology

Virulent Newcastle disease (VND), formerly exotic Newcastle disease, is a contagious viral avian disease affecting many domestic and wild bird species; it is transmissible to humans. Though there are rare cases where the disease gives a mild fever and/or conjunctivitis. Its effects are most notable in domestic poultry due to their high susceptibility and the potential for severe impacts of an epizootic on the poultry industries. It is endemic to many countries.

Immunopotentiator and vaccine preparation for emergency vaccination of Newcastle disease

InactiveCN104069480AProduced fastEasy to operateViral antigen ingredientsPeptide/protein ingredientsBiotechnologyHemagglutinin
The invention discloses an immunopotentiator and a vaccine preparation for emergency vaccination of Newcastle disease. The active ingredient of the immunopotentiator is composed of sword bean hemagglutinin, panaxoside and astragalus polysaccharide; the vaccine preparation for emergency vaccination of Newcastle disease is composed of the immunopotentiator and Newcastle disease inactivated vaccine according to a volume ratio of 1: (5-25). After being emergently inoculated to chicken, the vaccine preparation disclosed by the invention can be used for effectively controlling the development of epidemic situation and replacing emergently inoculated virulent or attenuated vaccine, the attenuated vaccine not only brings poison and has the possibility of strong virulence return; on the other hand, the vaccine preparation can be used for compensating the defects of slow generation of antibody of the inactivated vaccine to unfavorably control the epidemic situation; meanwhile, the active ingredient of the immunopotentiator is composed of sword bean hemagglutinin, panaxoside and astragalus polysaccharide, and these extracts are active components extracted from plants, thereby meeting the requirements of environmental protection, moreover, the method is simple to operate, capable of quickly generating protective antibody, safe and effective, thereby having promotion significance.
Owner:GUANGZHOU SOUTH CHINA BIOLOGICAL MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products